Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Parcell

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|November 21, 2012
Time to debate rapid molecular testing for tuberculosis?Benjamin J Parcell, Michael Lockhart
Mathematical Biosciences and Engineering : MBE|December 31, 2020
Modelling the transmission of infectious diseases inside hospital bays: implications for COVID-19David Moreno Martos, Benjamin J Parcell, Raluca Eftimie
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2024
Application of Pathogen Genomics to Outbreak InvestigationBenjamin J Parcell, Kerry A Pettigrew, Katarina Oravcova
Journal of Medical Microbiology|June 18, 2026
Investigation of the efficacy of high-dose flucloxacillin therapy for borderline oxacillin-resistant (BORSA) <i>Staphylococcus aureus</i> infections of <i>Galleria mellonella</i> larvaeDorian Jones, Benjamin J Parcell, Peter J Coote
Infection Control and Hospital Epidemiology|November 15, 2013
Development of a core team for the management of peripherally inserted central cathetersBenjamin J Parcell, Lasantha Ratnayake, Ian Zealley, et al.
Pathogens and Disease|October 14, 2020
Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains of Klebsiella pneumoniaeAlexandra E DeSarno, Benjamin J Parcell, Peter J Coote
Journal of Medical Microbiology|February 28, 2024
Rapid determination of antimicrobial susceptibility of Gram-negative bacteria from clinical blood cultures using a scattered light-integrated collection deviceKerry Falconer, Robert Hammond, Benjamin J Parcell, et al.
Journal of Medical Microbiology|January 6, 2025
Investigating the time to blood culture positivity: why does it take so long?Kerry Falconer, Robert Hammond, Benjamin J Parcell, et al.
Antibiotics (Basel, Switzerland)|February 23, 2024
Repurposing Mitomycin C in Combination with Pentamidine or Gentamicin to Treat Infections with Multi-Drug-Resistant (MDR) <i>Pseudomonas aeruginosa</i>Elin Svedholm, Benjamin Bruce, Benjamin J Parcell, et al.
Antibiotics (Basel, Switzerland)|August 26, 2023
Combination Therapy with Ciprofloxacin and Pentamidine against Multidrug-Resistant <i>Pseudomonas aeruginosa</i>: Assessment of In Vitro and In Vivo Efficacy and the Role of Resistance-Nodulation-Division (RND) Efflux PumpsMegan Fletcher, Alex McCormack, Benjamin J Parcell, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|November 21, 2012
Time to debate rapid molecular testing for tuberculosis?Benjamin J Parcell, Michael Lockhart
Mathematical Biosciences and Engineering : MBE|December 31, 2020
Modelling the transmission of infectious diseases inside hospital bays: implications for COVID-19David Moreno Martos, Benjamin J Parcell, Raluca Eftimie
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2024
Application of Pathogen Genomics to Outbreak InvestigationBenjamin J Parcell, Kerry A Pettigrew, Katarina Oravcova
Journal of Medical Microbiology|June 18, 2026
Investigation of the efficacy of high-dose flucloxacillin therapy for borderline oxacillin-resistant (BORSA) <i>Staphylococcus aureus</i> infections of <i>Galleria mellonella</i> larvaeDorian Jones, Benjamin J Parcell, Peter J Coote
Infection Control and Hospital Epidemiology|November 15, 2013
Development of a core team for the management of peripherally inserted central cathetersBenjamin J Parcell, Lasantha Ratnayake, Ian Zealley, et al.
Pathogens and Disease|October 14, 2020
Repurposing the anti-viral drug zidovudine (AZT) in combination with meropenem as an effective treatment for infections with multi-drug resistant, carbapenemase-producing strains of Klebsiella pneumoniaeAlexandra E DeSarno, Benjamin J Parcell, Peter J Coote
Journal of Medical Microbiology|February 28, 2024
Rapid determination of antimicrobial susceptibility of Gram-negative bacteria from clinical blood cultures using a scattered light-integrated collection deviceKerry Falconer, Robert Hammond, Benjamin J Parcell, et al.
Journal of Medical Microbiology|January 6, 2025
Investigating the time to blood culture positivity: why does it take so long?Kerry Falconer, Robert Hammond, Benjamin J Parcell, et al.
Antibiotics (Basel, Switzerland)|February 23, 2024
Repurposing Mitomycin C in Combination with Pentamidine or Gentamicin to Treat Infections with Multi-Drug-Resistant (MDR) <i>Pseudomonas aeruginosa</i>Elin Svedholm, Benjamin Bruce, Benjamin J Parcell, et al.
Antibiotics (Basel, Switzerland)|August 26, 2023
Combination Therapy with Ciprofloxacin and Pentamidine against Multidrug-Resistant <i>Pseudomonas aeruginosa</i>: Assessment of In Vitro and In Vivo Efficacy and the Role of Resistance-Nodulation-Division (RND) Efflux PumpsMegan Fletcher, Alex McCormack, Benjamin J Parcell, et al.
Pageof 5